In a reversal of a past acquisition, Takeda Pharmaceutical Co. Ltd. is to fully divest all its shares and assets in Multilab Indústria e Comércio de Produtos Farma in Brazil to Novamed, part of the Brazilian NC Group that also owns several of the other large pharma firms in the country such as EMS and Germed.
The move appears to be in line with the leading Japanese pharma firm’s stated desire to focus more on its...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
